Peer Reviewed Cancer Research Program Fiscal Year 2012 Report to Congress
Abstract
The U.S. Army Medical Research and Materiel Command (USAMRMC) is a major subordinate Command of the U.S. Army Medical Command. The USAMRMC manages biomedical research and development programs that are part of the Department of Defense (DoD). Congressional appropriations totaling over $6 billion for fiscal years 1992 to 2012 (FY92-FY12) assigned to the USAMRMC are managed by the office of the Congressionally Directed Medical Research Programs (CDMRP), a subordinate organization within the USAMRMC. Biomedical research supported by these funds include research in breast, prostate, lung, ovarian, melanoma and genetic cancers; pediatric brain tumors, neurofibromatosis; tuberous sclerosis complex; autism; Gulf War illness; psychological health and traumatic brain injury; deployment-related medical; and other research. The CDMRP is responsible for planning, coordinating, integrating, programming, budgeting, and executing the research programs. The CDMRP s flexible execution and management cycle includes the receipt of annual congressional appropriations, new research programs stakeholders meeting, vision setting, release of request for preproposals or applications, preproposal screening and invitation to submit full applications, full applications receipt and review, recommendation of grants for funding, and oversight of research grants.
Document Details
- Document Type
- Technical Report
- Publication Date
- Feb 21, 2012
- Accession Number
- ADA558259
Entities
Organizations
- United States Army Medical Research and Development Command